Warfarin (also known as a blood thinner) is a chemical substance that prevents or reduces blood coagulation and prolongs the blood clotting time. These drugs are majorly used for high risk of blood clots in various medical conditions, such as atrial fibrillation, deep vein thrombosis, myocardial infarction, pulmonary embolism, stroke, and others. Warfarin often plays a crucial role in human cardiovascular health protection by controlling and preventing the formation of blood clots.
MARKET SCOPE
The "Global Warfarin Market Analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Warfarin market with detailed market segmentation by route of administration, application, and geography. The report provides key statistics on the market status of the leading Warfarin market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
-Based on route of administration, the global Warfarin market is segmented into oral warfarin, intravenous warfarin.
-On the basis of application, the market is segmented into atrial fibrillation and heart attack, stroke, deep vein thrombosis (dvt), pulmonary embolism (pe), others.
MARKET DYNAMICS
Drivers
-Rise in the prevalence of venous thromboembolism (VTE) and cardiovascular disorders.
-Rise in the obese and geriatric population.
-Increase in acceptance of novel oral anticoagulants (NOACs).
-Growing awareness of NOACs in the developing region.
Restraints
-The higher cost of NOACs and lack of antidotes for NOACs are the major restraining factor for this market.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Warfarin market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Warfarin market in these regions.
IMPACT OF COVID-19 ON WARFARIN MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
MARKET PLAYERS
The report covers key developments in the Warfarin market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Warfarin market are anticipated to lucrative growth opportunities in the future with the rising demand for Warfarin in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Warfarin market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
-Aspen Holdings
-Bayer AG
-Boehringer Ingelheim GmbH
-Bristol-Myers Squibb Company
-Daiichi Sankyo Company, Limited
-GlaxoSmithKline plc.
-Johnson & Johnson (Janssen Pharmaceuticals, Inc.)
-Pfizer, Inc.
-Portola Pharmaceuticals, Inc.
-Sanofi S.A
The Insight Partner's dediWarfarined research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.